Abstract
Patients with diabetes who are infected with severe acute respiratory syndrome coronavirus 2 experience a worsening of glycaemic control and are at increased risk for severe outcomes. Little is known regarding the impact of COVID-19 vaccinations on glycaemic control. This case report explores a patient with diabetes who experienced an acute worsening of glucose control in the week following the second dose of the Pfizer-BioNTech COVID-19 vaccine.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
